Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Prevalence of dyslipidemia in resource-limited settings is not well characterized
  • Emerging data suggest that dyslipidemia and other metabolic toxicities are associated with HIV and ART in many developing countries[George 2009; Mutimura 2007; Manuthu 2008; Hiransuthikul 2007; Muyanja 2016; Nguyen 2016]
  • Extreme poverty limits the ability of individuals to make choices about dietary intake and hinders healthy lifestyle patterns

Action required

Keywords: Cardiovascular Disease, Dyslipidemia, Resource-Limited Settings, Treatment Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.